\ud Home-management of malaria (HMM) strategy improves early access of anti-malarial medicines to high-risk groups in remote areas of sub-Saharan Africa. However, limited data are available on the effectiveness of using artemisinin-based combination therapy (ACT) within the HMM strategy. The aim of this study was to assess the effectiveness of artemether-lumefantrine (AL), presently the most favoured ACT in Africa, in under-five children with uncomplicated Plasmodium falciparum malaria in Tanzania, when provided by community health workers (CHWs) and administered unsupervised by parents or guardians at home. An open label, single arm prospective study was conducted in two rural villages with high malaria transmission in Kibaha District, Tan...
BACKGROUND\ud \ud Tanzania switched the antimalarial first line to sulphadoxine-pyrimethamine (SP) i...
\ud \ud Drug resistance to anti-malarials is a major public health problem worldwide. This study aim...
BACKGROUND\ud \ud Drug resistance to anti-malarials is a major public health problem worldwide. This...
Background: Home-management of malaria (HMM) strategy improves early access of anti-malarial medicin...
Background: Home-management of malaria (HMM) strategy improves early access of anti-malarial medicin...
BACKGROUND: Home-management of malaria (HMM) strategy improves early access of anti-malarial medicin...
Background: Home-management of malaria (HMM) strategy improves early access of anti-malarial medicin...
Early parasite-based diagnosis of malaria prior to treatment is critical for rational drug use, opti...
Tanzania adopted artemether-lumefantrine (AL) as first-line drug for uncomplicated malaria in 2006. ...
Background: The six dose regimen of Artemether- Lumefantrine (AL), has high efficacy in clinical tri...
BACKGROUND: The use of artemisinin-based combination therapy (ACT) at the community level has been a...
Tanzania has high burden of morbidity and mortality caused by malaria which is the leading cause of...
Background: Tanzania adopted artemether-lumefantrine (AL) as first-line drug for uncomplicated malar...
Background: Artemether/lumefantrine (Coartem (R)) has been used as a treatment for uncomplicated Pla...
Research Artice published by BioMed CentralBackground: The World Health Organization recommends that...
BACKGROUND\ud \ud Tanzania switched the antimalarial first line to sulphadoxine-pyrimethamine (SP) i...
\ud \ud Drug resistance to anti-malarials is a major public health problem worldwide. This study aim...
BACKGROUND\ud \ud Drug resistance to anti-malarials is a major public health problem worldwide. This...
Background: Home-management of malaria (HMM) strategy improves early access of anti-malarial medicin...
Background: Home-management of malaria (HMM) strategy improves early access of anti-malarial medicin...
BACKGROUND: Home-management of malaria (HMM) strategy improves early access of anti-malarial medicin...
Background: Home-management of malaria (HMM) strategy improves early access of anti-malarial medicin...
Early parasite-based diagnosis of malaria prior to treatment is critical for rational drug use, opti...
Tanzania adopted artemether-lumefantrine (AL) as first-line drug for uncomplicated malaria in 2006. ...
Background: The six dose regimen of Artemether- Lumefantrine (AL), has high efficacy in clinical tri...
BACKGROUND: The use of artemisinin-based combination therapy (ACT) at the community level has been a...
Tanzania has high burden of morbidity and mortality caused by malaria which is the leading cause of...
Background: Tanzania adopted artemether-lumefantrine (AL) as first-line drug for uncomplicated malar...
Background: Artemether/lumefantrine (Coartem (R)) has been used as a treatment for uncomplicated Pla...
Research Artice published by BioMed CentralBackground: The World Health Organization recommends that...
BACKGROUND\ud \ud Tanzania switched the antimalarial first line to sulphadoxine-pyrimethamine (SP) i...
\ud \ud Drug resistance to anti-malarials is a major public health problem worldwide. This study aim...
BACKGROUND\ud \ud Drug resistance to anti-malarials is a major public health problem worldwide. This...